Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Avalo Therapeutics (AVTX) Amortization - Intangibles (2017 - 2022)

Avalo Therapeutics' Amortization - Intangibles history spans 6 years, with the latest figure at $38000.0 for Q1 2022.

  • For Q1 2022, Amortization - Intangibles fell 91.04% year-over-year to $38000.0; the TTM value through Dec 2022 reached $38000.0, down 97.54%, while the annual FY2022 figure was $38000.0, 97.54% down from the prior year.
  • Amortization - Intangibles reached $38000.0 in Q1 2022 per AVTX's latest filing, down from $266000.0 in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $1.2 million in Q2 2018 to a low of -$1.5 million in Q4 2018.
  • Average Amortization - Intangibles over 5 years is $381973.3, with a median of $404000.0 recorded in 2020.
  • Peak YoY movement for Amortization - Intangibles: crashed 471.82% in 2018, then skyrocketed 122.51% in 2019.
  • A 5-year view of Amortization - Intangibles shows it stood at -$1.5 million in 2018, then surged by 122.51% to $334753.0 in 2019, then surged by 50.26% to $503000.0 in 2020, then tumbled by 47.12% to $266000.0 in 2021, then crashed by 85.71% to $38000.0 in 2022.
  • Per Business Quant, the three most recent readings for AVTX's Amortization - Intangibles are $38000.0 (Q1 2022), $266000.0 (Q4 2021), and $428000.0 (Q3 2021).